BIOMAT Database Logo BIOMAT Database Logo

The role of renal dopamine and PGE2 in mediating the renal effects of the antihypertensive loop diuretic piretanide. 1987

P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Department of Medicine, Western General Hospital, Edinburgh, Scotland, United Kingdom.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008138 Loop of Henle The U-shaped portion of the renal tubule in the KIDNEY MEDULLA, consisting of a descending limb and an ascending limb. It is situated between the PROXIMAL KIDNEY TUBULE and the DISTAL KIDNEY TUBULE. Ascending Limb of Loop of Henle,Descending Limb of Loop of Henle,Henle Loop
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine

Related Publications

P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Pharmacokinetics of the loop diuretic piretanide in renal failure.
January 1985, European journal of clinical pharmacology,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
February 1987, Clinical cardiology,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.
March 1983, British journal of clinical pharmacology,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.
January 1984, European journal of clinical pharmacology,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.
January 1984, Pharmacotherapy,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Piretanide: effective diuretic in renal failure.
January 1981, The Medical journal of Australia,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
[Effect of a loop diuretic, piretanide, in severe cardiac insufficiency].
January 1984, Medicina,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Analysis of the natriuretic action of a loop diuretic, piretanide, in man.
April 1991, British journal of clinical pharmacology,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Acute and chronic effects of the loop diuretic, piretanide, on baroreflex set point and sensitivity in hypertensive man.
October 1985, Journal of hypertension,
P L Padfield, and R K Hindawi, and J Corrie, and M A Reid, and D Chalmers, and B C Williams, and M Rademaker
Renal and hemodynamic effects of non-diuretic antihypertensive therapy.
September 1986, Seminars in nephrology,
Copied contents to your clipboard!